Colorectal cancer (CRC) is the 3rd common cancer in the world. Because the five-year survival rate is below 60 % in the patients with CRC, two important respects in CRC researches are early diagnosis and more effective chemotherapeutic drugs. In fact, the studies on molecular pathology of CRC can resolve these two problems. Insulin has a role in the carcinogenesis and developments of CRC, and 5-FU is a standard chemotherapeutic drug for the patients with stage III CRC. As a human securin, PTTG has a major role in many functions. In our studies of 2-D proteomics, PTTG correlates with the invasiveness of CRC. Besides, it is found to be highly expressed in many types of cancer, but the expression of PTTG is, however, low or undetectable in normal tissues. This character of tumor-specific expression is suitable for drug and target therapy. Therefore, we use cell line HT-29 to study the effects of 5-FU and insulin on the expression of PTTG. We have found that insulin in the physiologic level up-regulates PTTG. In normal physiologic level, insulin up-regulates PTTG, in a dose-dependent manner. On the other hand, the induction of PTTG by insulin more than normal physiologic level is decreased. In the studies with 5-FU, PTTG has a higher level after treatment, but not in dose-dependent manner. The up-regulation of PTTG by 5-FU is decreased in a higher dose. In cancer cells, insulin regulated pathways may contribute to the growth, proliferation, and apoptosis of tumors by activating oncogenic molecular targets such as PTTG. We have showed that insulin of bio-physiologic level can up-regulate PTTG in colon cancer HT-29 cell lines. Induction of PTTG by insulin suggests a mechanism by which insulin may contribute to the development and/or progression of colon cancers. To tumor- specific expression of PTTG, induction of PTTG by insulin, consequently, may be a target of colon cancer treatment. In the studies of 5-FU and PTTG, we have found that 5-FU in HT-29 cells can induce PTTG, with a peak effect in a dose around IC50. Interestingly, the induction of PTTG is decreased in a higher dose of 5-FU. This is a new finding in the effect of 5-FU on PTTG. Accordingly, we can realize why PTTG in some studies is suppressed; the others have a higher level. More importantly, the connection of PTTG expression between sister chromatic separation and DNA repair after DNA damage is more reasonable. Based on this finding, we propose that PTTG connects DNA damage response pathways, sister chromatic separation and apoptosis after DNA damage. Therefore, PTTG has a key role after DNA damage, deciding cells to have DNA repair/cell cycle arrest or to progress to apoptosis.

Meiosis is a specialized cell cycle, which generates haploid gametes from diploid parental cells. During meiosis one round of cohesion establishment during premeiotic DNA replication mediates two rounds of chromosome segregation. During meiosis I homologous chromosomes separate, whereas sister chromatids segregate during the second meiotic division without an intervening round of DNA replication. Both rounds of chromosome segregation are triggered by an ubiquitin ligase called the Anaphase-Promoting Complex or Cyclosome (APC/C). APC/C-dependent destruction of securin/Pds1 is required to activate separase, a thiol protease that mediates chromosome segregation by cleavage of the cohesin complex. The first meiotic division is preceded by an extended prophase I, during which maternal and paternal chromatids undergo recombination. The persistence of cohesion during premeiotic S- and prophase I is essential for recombination and both meiotic nuclear divisions. In order to prevent premature loss of cohesion, the APC/C has to be inactivated during early meiosis. How the APC/C is kept inactive during premeiotic S- and prophase I was unknown. This question has been addressed by studying the APC/C subunit Mnd2 from the budding yeast Saccharomyces cerevisiae. This work demonstrates that Mnd2 is required for the persistence of cohesion during premeiotic S- and prophase I. Mnd2 prevents premature activation of the APC/C by the meiosis-specific substrate recognition factor Ama1. In cells lacking Mnd2, the APC/C-Ama1 enzyme triggers premature ubiquitin-dependent degradation of Pds1, which leads to premature separation of sister chromatids due to an unrestrained activity of separase. Thus, chromosome segregation during meiosis depends on both inhibition of a meiosis-specific APC/C and timely activation of APC/C- dependent proteolysis. / Die Meiose ist ein spezialisierter Zellzyklus, der zum Ziel hat haploide Gameten aus diploiden Vorläuferzellen zu produzieren. Dafür erfolgen nach der prä-meiotischen DNA Replikation zwei aufeinanderfolgende Kernteilungen. In der ersten meiotischen Teilung erfolgt die Trennung der homologen Chromosomen. In einer zweiten meiotischen Teilung werden dann die Schwesterchromatiden getrennt. Die Trennung der Chromosomen wird durch den Anaphase-Promoting Complex oder Cyclosome (APC/C), einer Ubiquitin Ligase, reguliert. Der APC/C initiiert den Abbau von Securin/Pds1, einem Inhibitor der Thiol-Protease Separase, welche für die Trennung der Chromosomen zum Beginn der Anaphase verantwortlich ist. In einer im Vergleich zur Mitose extrem langen meiotischen Prophase I findet Rekombination zwischen maternalen und paternalen Chromosomen statt. Für diesen Vorgang, sowie für die beiden folgenden meiotischen Teilungen, wird Kohäsion zwischen den Schwesterchromatiden benötigt. Ein frühzeitiger Verlust der Kohäsion führt zur frühzeitigen Trennnung der Schwesterchromatiden, wodurch aneuploide Gameten produziert werden können. Daher muss die Aktivität des APC/C während der meiotischen Prophase I inhibiert werden. Wie der APC/C während der Prophase I inaktiviert wird, war bisher unbekannt. Einsicht in dieses Problem ergab sich aus der Untersuchung der APC/C Untereinheit Mnd2 aus der Bäckerhefe Saccharomyces cerevisiae. Es wird gezeigt, dass Mnd2 für den Verbleib der Kohäsion zwischen den Schwesterchromatiden während der meiotischen S- und Prophase I benötigt wird. Während dieser Phase verhindert Mnd2 die frühzeitige Aktivierung der Meiose-spezifischen Form des APC/C-Ama1. In meiotischen Zellen, die kein Mnd2 besitzen, löst das APC/C-Ama1 Enzym die Ubiquitin-abhängige Zerstörung von Pds1 aus. Dies führt zu einer frühzeitigen Aktivierung von Separase, welches die Trennung der Schwesterchromatiden schon während der meiotischen S- und Prophase I zur Folge hat. Die korrekte Verteilung der Chromosomen hängt daher sowohl von der Inhibierung als auch der Aktivierung des APC/C ab.

Meiosis is a specialized cell cycle, which generates haploid gametes from diploid parental cells. During meiosis one round of cohesion establishment during premeiotic DNA replication mediates two rounds of chromosome segregation. During meiosis I homologous chromosomes separate, whereas sister chromatids segregate during the second meiotic division without an intervening round of DNA replication. Both rounds of chromosome segregation are triggered by an ubiquitin ligase called the Anaphase-Promoting Complex or Cyclosome (APC/C). APC/C-dependent destruction of securin/Pds1 is required to activate separase, a thiol protease that mediates chromosome segregation by cleavage of the cohesin complex. The first meiotic division is preceded by an extended prophase I, during which maternal and paternal chromatids undergo recombination. The persistence of cohesion during premeiotic S- and prophase I is essential for recombination and both meiotic nuclear divisions. In order to prevent premature loss of cohesion, the APC/C has to be inactivated during early meiosis. How the APC/C is kept inactive during premeiotic S- and prophase I was unknown. This question has been addressed by studying the APC/C subunit Mnd2 from the budding yeast Saccharomyces cerevisiae. This work demonstrates that Mnd2 is required for the persistence of cohesion during premeiotic S- and prophase I. Mnd2 prevents premature activation of the APC/C by the meiosis-specific substrate recognition factor Ama1. In cells lacking Mnd2, the APC/C-Ama1 enzyme triggers premature ubiquitin-dependent degradation of Pds1, which leads to premature separation of sister chromatids due to an unrestrained activity of separase. Thus, chromosome segregation during meiosis depends on both inhibition of a meiosis-specific APC/C and timely activation of APC/C- dependent proteolysis. / Die Meiose ist ein spezialisierter Zellzyklus, der zum Ziel hat haploide Gameten aus diploiden Vorläuferzellen zu produzieren. Dafür erfolgen nach der prä-meiotischen DNA Replikation zwei aufeinanderfolgende Kernteilungen. In der ersten meiotischen Teilung erfolgt die Trennung der homologen Chromosomen. In einer zweiten meiotischen Teilung werden dann die Schwesterchromatiden getrennt. Die Trennung der Chromosomen wird durch den Anaphase-Promoting Complex oder Cyclosome (APC/C), einer Ubiquitin Ligase, reguliert. Der APC/C initiiert den Abbau von Securin/Pds1, einem Inhibitor der Thiol-Protease Separase, welche für die Trennung der Chromosomen zum Beginn der Anaphase verantwortlich ist. In einer im Vergleich zur Mitose extrem langen meiotischen Prophase I findet Rekombination zwischen maternalen und paternalen Chromosomen statt. Für diesen Vorgang, sowie für die beiden folgenden meiotischen Teilungen, wird Kohäsion zwischen den Schwesterchromatiden benötigt. Ein frühzeitiger Verlust der Kohäsion führt zur frühzeitigen Trennnung der Schwesterchromatiden, wodurch aneuploide Gameten produziert werden können. Daher muss die Aktivität des APC/C während der meiotischen Prophase I inhibiert werden. Wie der APC/C während der Prophase I inaktiviert wird, war bisher unbekannt. Einsicht in dieses Problem ergab sich aus der Untersuchung der APC/C Untereinheit Mnd2 aus der Bäckerhefe Saccharomyces cerevisiae. Es wird gezeigt, dass Mnd2 für den Verbleib der Kohäsion zwischen den Schwesterchromatiden während der meiotischen S- und Prophase I benötigt wird. Während dieser Phase verhindert Mnd2 die frühzeitige Aktivierung der Meiose-spezifischen Form des APC/C-Ama1. In meiotischen Zellen, die kein Mnd2 besitzen, löst das APC/C-Ama1 Enzym die Ubiquitin-abhängige Zerstörung von Pds1 aus. Dies führt zu einer frühzeitigen Aktivierung von Separase, welches die Trennung der Schwesterchromatiden schon während der meiotischen S- und Prophase I zur Folge hat. Die korrekte Verteilung der Chromosomen hängt daher sowohl von der Inhibierung als auch der Aktivierung des APC/C ab.

INTRODUÇÃO: A Leucemia/linfoma de células T do Adulto (ATL) é uma doença maligna de fenótipo T CD3+/CD4+/CD25+/CD7- e, geneticamente, apresenta cariótipo complexo e aneuploidia. Clinicamente muito agressiva e ainda incurável, está associada ao vírus linfotrópico T humano do tipo-1 que, preferencialmente, infecta linfócitos T CD4+. Dos indivíduos portadores do HTLV-1, somente 3-5% irão evoluir para ATL e após longo período de latência. Entretanto, os fatores virais ou do hospedeiro que estão associados com a progressão para ATL permanecem desconhecidos. O proto-oncogene hSecurina é um regulador mitótico importante para o processo de segregação cromossômica durante a separação das cromátides irmãs e está envolvido na patogênese de vários tumores. Com o objetivo de avaliar o conteúdo de DNA, o ciclo celular e a expressão do gene hSecurina em células T CD4+ e CD8+ dos portadores assintomáticos do HTLV-1 em comparação com ATL e indivíduos saudáveis, nos propusemos a realizar o presente estudo. MÉTODOS: Foram avaliados 38 portadores assintomáticos do HTLV-1, 20 casos de ATL pareados por sexo e idade com 35 indivíduos saudáveis. Foram estudados, individualmente, os subtipos linfocitários T CD4+ e CD8+, sendo o ciclo celular avaliado por citometria de fluxo e a expressão do gene hSecurina pela reação em cadeia da polimerase quantitativa em Tempo Real. RESULTADOS: Neste estudo, observamos parada de maturação de linfócitos T CD4+ na fase G0/G1 em portadores assintomáticos do HTLV-1 com diferença estatisticamente significante em comparação aos grupos-controle (p=0,041) e ATL (p=0,023). No grupo de portadores assintomáticos, observamos correlação inversa entre a porcentagem de células em G0/G1 e expressão de hSecurina (p=0,018) em linfócitos T CD4+. Porém, neste mesmo grupo, houve correlação direta entre porcentagem de células em fase S e expressão de hSecurina em linfócitos T CD4+ (p=0,001). Como esperado, observou-se maior fase S em ATL em comparação aos grupos-controle (p=0,020) e portador do HTLV-1 (p < 0,001). CONCLUSÃO: Neste estudo, demonstramos que linfócitos T CD4+ de portadores assintomáticos do vírus HTLV-1 apresentam atraso no ciclo celular com aumento de células na fase G0/G1. Este retardo da progressão do ciclo celular correlacionou-se de forma inversamente proporcional à expressão do gene hSecurina / INTRODUCTION: Adult T-Cell Leukemia (ATL) is a malignant disease of the CD3+/CD4+/CD25+/CD7- T-lymphocytes and genetically features complex karyotypes and aneuploidy. It is a clinically aggressive disease, which is yet incurable. It is associated with the human T-cell leukemia virus type 1 (HTLV-1) that preferentially infects CD4+ T-lymphocytes. Among all individuals that carry HTLV-1, only 3-5% will develop ATL and that too after a long latency period. However, the viral or host factors that are associated with the progression of ATL remain unknown. The proto-oncogene hSecurin is an important mitotic regulator for the process of chromosome segregation during sister chromatid separation and is involved in the pathogenesis of various tumors. We decided to conduct this study in order to analyze the DNA content, cell cycle, and expression of the hSecurin gene in CD4+ and CD8+ T cells of asymptomatic HTLV-1 carriers compared with that in ATL and healthy individuals. METHODS: We evaluated 38 asymptomatic HTLV-1 carriers, 20 patients with ATL, and 35 healthy subjects paired by sex and age. We individually studied the lymphocyte subtypes T CD4+ and CD8+; their cell cycles were evaluated by flow cytometry, and the expression of the hSecurin gene was analyzed using quantitative real time polymerase chain reaction. RESULTS: We observed lymphocyte maturation arrest in CD4+ T cells in the G0/G1 phase of asymptomatic HTLV-1 carriers with a statistically significant difference compared to that in the control (p = 0.041) and ATL (p = 0.023) groups. In the asymptomatic HTLV-1 carrier group, we also found an inverse correlation between the percentage of cells in G0/G1 phase and the hSecurin expression (p = 0.018) in TCD4+ lymphocytes. However, in this same group, there was also a direct correlation between the percentage of S phase cells and hSecurin expression in TCD4+ lymphocytes (p = 0.001). As expected, there was a higher number of S phase cells in the ATL group compared to that in the control (p = 0.020) and asymptomatic HTLV-1 carrier (p < 0.001) groups. CONCLUSION: In this study, we demonstrated that CD4 + T lymphocytes from asymptomatic HTLV-1 virus carriers present cell cycle arrest with increased G0/G1 phase cells. This delay in cell cycle progression correlated inversely with the expression of the hSecurin gene

INTRODUÇÃO: A Leucemia/linfoma de células T do Adulto (ATL) é uma doença maligna de fenótipo T CD3+/CD4+/CD25+/CD7- e, geneticamente, apresenta cariótipo complexo e aneuploidia. Clinicamente muito agressiva e ainda incurável, está associada ao vírus linfotrópico T humano do tipo-1 que, preferencialmente, infecta linfócitos T CD4+. Dos indivíduos portadores do HTLV-1, somente 3-5% irão evoluir para ATL e após longo período de latência. Entretanto, os fatores virais ou do hospedeiro que estão associados com a progressão para ATL permanecem desconhecidos. O proto-oncogene hSecurina é um regulador mitótico importante para o processo de segregação cromossômica durante a separação das cromátides irmãs e está envolvido na patogênese de vários tumores. Com o objetivo de avaliar o conteúdo de DNA, o ciclo celular e a expressão do gene hSecurina em células T CD4+ e CD8+ dos portadores assintomáticos do HTLV-1 em comparação com ATL e indivíduos saudáveis, nos propusemos a realizar o presente estudo. MÉTODOS: Foram avaliados 38 portadores assintomáticos do HTLV-1, 20 casos de ATL pareados por sexo e idade com 35 indivíduos saudáveis. Foram estudados, individualmente, os subtipos linfocitários T CD4+ e CD8+, sendo o ciclo celular avaliado por citometria de fluxo e a expressão do gene hSecurina pela reação em cadeia da polimerase quantitativa em Tempo Real. RESULTADOS: Neste estudo, observamos parada de maturação de linfócitos T CD4+ na fase G0/G1 em portadores assintomáticos do HTLV-1 com diferença estatisticamente significante em comparação aos grupos-controle (p=0,041) e ATL (p=0,023). No grupo de portadores assintomáticos, observamos correlação inversa entre a porcentagem de células em G0/G1 e expressão de hSecurina (p=0,018) em linfócitos T CD4+. Porém, neste mesmo grupo, houve correlação direta entre porcentagem de células em fase S e expressão de hSecurina em linfócitos T CD4+ (p=0,001). Como esperado, observou-se maior fase S em ATL em comparação aos grupos-controle (p=0,020) e portador do HTLV-1 (p < 0,001). CONCLUSÃO: Neste estudo, demonstramos que linfócitos T CD4+ de portadores assintomáticos do vírus HTLV-1 apresentam atraso no ciclo celular com aumento de células na fase G0/G1. Este retardo da progressão do ciclo celular correlacionou-se de forma inversamente proporcional à expressão do gene hSecurina / INTRODUCTION: Adult T-Cell Leukemia (ATL) is a malignant disease of the CD3+/CD4+/CD25+/CD7- T-lymphocytes and genetically features complex karyotypes and aneuploidy. It is a clinically aggressive disease, which is yet incurable. It is associated with the human T-cell leukemia virus type 1 (HTLV-1) that preferentially infects CD4+ T-lymphocytes. Among all individuals that carry HTLV-1, only 3-5% will develop ATL and that too after a long latency period. However, the viral or host factors that are associated with the progression of ATL remain unknown. The proto-oncogene hSecurin is an important mitotic regulator for the process of chromosome segregation during sister chromatid separation and is involved in the pathogenesis of various tumors. We decided to conduct this study in order to analyze the DNA content, cell cycle, and expression of the hSecurin gene in CD4+ and CD8+ T cells of asymptomatic HTLV-1 carriers compared with that in ATL and healthy individuals. METHODS: We evaluated 38 asymptomatic HTLV-1 carriers, 20 patients with ATL, and 35 healthy subjects paired by sex and age. We individually studied the lymphocyte subtypes T CD4+ and CD8+; their cell cycles were evaluated by flow cytometry, and the expression of the hSecurin gene was analyzed using quantitative real time polymerase chain reaction. RESULTS: We observed lymphocyte maturation arrest in CD4+ T cells in the G0/G1 phase of asymptomatic HTLV-1 carriers with a statistically significant difference compared to that in the control (p = 0.041) and ATL (p = 0.023) groups. In the asymptomatic HTLV-1 carrier group, we also found an inverse correlation between the percentage of cells in G0/G1 phase and the hSecurin expression (p = 0.018) in TCD4+ lymphocytes. However, in this same group, there was also a direct correlation between the percentage of S phase cells and hSecurin expression in TCD4+ lymphocytes (p = 0.001). As expected, there was a higher number of S phase cells in the ATL group compared to that in the control (p = 0.020) and asymptomatic HTLV-1 carrier (p < 0.001) groups. CONCLUSION: In this study, we demonstrated that CD4 + T lymphocytes from asymptomatic HTLV-1 virus carriers present cell cycle arrest with increased G0/G1 phase cells. This delay in cell cycle progression correlated inversely with the expression of the hSecurin gene